Netherlands joins Ireland in vaccine suspension over blood clot concerns
theguardian.com
theguardian.com
"Around 17 million people in the EU and UK have now received our vaccine, and the number of cases of blood clots reported in this group is lower than the hundreds of cases that would be expected among the general population," said Ann Taylor, the firm's chief medical officer. "The nature of the pandemic has led to increased attention in individual cases and we are going beyond the standard practices for safety monitoring of licensed medicines in reporting vaccine events, to ensure public safety."
If 6-7 billion people end up getting vaccinated, then multiple people will experience things that are literally one in a billion chances. Maybe spontaneous combustion.
If in the near future, public mistrust about this brand of vaccine climbs higher but confidence in other vaccines does not drop as much, then governments will benefit from having deferred deployment of this vaccine, and they may benefit further by suspending deployment of this vaccine entirely, even if the vaccine is entirely vindicated to be safe.
This outcome would be unfair for the manufacturer, but it would sacrifice this brand to preserve public trust. Public trust is a key factor in healthcare policy in societies where some healthcare participation is voluntary and elections can significantly influence policy priorities.